Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Crotti

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|June 19, 2019
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritisChiara Crotti, Martina Biggioggero, Andrea Becciolini, et al.
Drugs in Context|November 7, 2019
Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritisMartina Biggioggero, Andrea Becciolini, Chiara Crotti, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2025
Osteoclast in CRPS: an alleged guilty fully acquittedMassimo Varenna, Francesca Zucchi, Raffaele Di Taranto, et al.
Biomed Research International|November 9, 2018
The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and FutureMartina Biggioggero, Chiara Crotti, Andrea Becciolini, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|November 8, 2024
Is CRPS-1 a Chronic Disabling Disease? A Long-term, Real-Life Study on Patients Treated With NeridronateMassimo Varenna, Francesca Zucchi, Francesco Orsini, et al.
Drug Design, Development and Therapy|June 6, 2017
Profile of sarilumab and its potential in the treatment of rheumatoid arthritisMaria Gabriella Raimondo, Martina Biggioggero, Chiara Crotti, et al.
Drug Design, Development and Therapy|February 2, 2017
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to dateChiara Crotti, Maria Gabriella Raimondo, Andrea Becciolini, et al.
Journal of Bone and Mineral Metabolism|February 12, 2026
How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1Massimo Varenna, Raffaele Di Taranto, Francesco Orsini, et al.
Autoimmunity Reviews|October 18, 2017
The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectivesEnnio Giulio Favalli, Maria Gabriella Raimondo, Andrea Becciolini, et al.
The Journal of Rheumatology|December 3, 2016
The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical SettingMarco Di Carlo, Andrea Becciolini, Valentina Lato, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|June 19, 2019
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritisChiara Crotti, Martina Biggioggero, Andrea Becciolini, et al.
Drugs in Context|November 7, 2019
Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritisMartina Biggioggero, Andrea Becciolini, Chiara Crotti, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2025
Osteoclast in CRPS: an alleged guilty fully acquittedMassimo Varenna, Francesca Zucchi, Raffaele Di Taranto, et al.
Biomed Research International|November 9, 2018
The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and FutureMartina Biggioggero, Chiara Crotti, Andrea Becciolini, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|November 8, 2024
Is CRPS-1 a Chronic Disabling Disease? A Long-term, Real-Life Study on Patients Treated With NeridronateMassimo Varenna, Francesca Zucchi, Francesco Orsini, et al.
Drug Design, Development and Therapy|June 6, 2017
Profile of sarilumab and its potential in the treatment of rheumatoid arthritisMaria Gabriella Raimondo, Martina Biggioggero, Chiara Crotti, et al.
Drug Design, Development and Therapy|February 2, 2017
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to dateChiara Crotti, Maria Gabriella Raimondo, Andrea Becciolini, et al.
Journal of Bone and Mineral Metabolism|February 12, 2026
How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1Massimo Varenna, Raffaele Di Taranto, Francesco Orsini, et al.
Autoimmunity Reviews|October 18, 2017
The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectivesEnnio Giulio Favalli, Maria Gabriella Raimondo, Andrea Becciolini, et al.
The Journal of Rheumatology|December 3, 2016
The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical SettingMarco Di Carlo, Andrea Becciolini, Valentina Lato, et al.
Pageof 5